Dr Harendra Parekh (second from L) and research team looking at module

The University of Queensland has struck a deal with Canadian health and wellness company PreveCeutical Medical which could revolutionise the way patients take medical cannabis.

19 November 2021
The strategy is to prevent pain through a different mechanism to the available opioid drugs

Research to develop non-addictive analgesics that could potentially be used as alternatives to addictive opioid drugs such as codeine will be undertaken by UQ under an agreement with Canadian biomedical company PreveCeutical Medical Inc.

31 January 2018